Health1 min read

STAT+: Pharmalittle: We’re reading about Dems eyeing Trump MFN deals, fewer drug launches in Europe, and more

By · Via STAT Health · Published by Everything Blog

In short

Incoming Democratic committee chairs in both the House and Senate are prioritizing investigations into most-favored nation drug pricing deals struck with drug manufacturers. These arrangements tied Medicaid drug prices to lower costs paid in peer nations in an effort to force European governments to pay more. However, U.S. drug prices have not fallen as intended, while research indicates a severe decline in new pharmaceutical commercialization abroad.

Key points

  • Congressional Democrats plan to make Trump administration drug pricing agreements a prima…: Congressional Democrats plan to make Trump administration drug pricing agreements a primary target of health care oversight in January.
  • The most-favored nation pricing policy failed to lower elevated prescription drug costs f…: The most-favored nation pricing policy failed to lower elevated prescription drug costs for patients within the United States.
  • Efforts to pressure foreign payers have coincided with pharmaceutical companies holding b…: Efforts to pressure foreign payers have coincided with pharmaceutical companies holding back new treatments from European markets.

Sources checked by our analysis pipeline: 1

Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we invite you to join us for a needed cup of stimulation. Our choice today is butter pecan with a dollop of bourbon honey (for the curious, the honey is procured locally from a family with beehives in their backyard). Meanwhile, here is the latest menu of tidbits to help you on your way. We hope you conquer the world and have a wonderful day. And as always, please do stay in touch. We appreciate feedback, tips, and criticism. …

The incoming Democratic chairs of key committees have taken a new step toward investigating the most-favored nation drug pricing agreements between drugmakers and the Trump administration, STAT reports. The drug pricing deals are expected to be a top health care oversight priority for Democrats once they take the majority in January. Earlier this year, the…

Health